Price movement over the last 24 hours
Arkham vs Bio Protocol — how do they compare? Arkham trades at Rp1,991 (market cap Rp450,94M, Rp516,11M 24h volume), while Bio Protocol trades at Rp511.72 (market cap Rp1,13T, Rp315,29M 24h volume). The key difference: Bio Protocol is far larger — about 2505.9× Arkham's market cap, and Arkham's circulating supply is 225,1M / 1B ARKM (23%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Arkham for 49 Days and Bio Protocol for 16 Days on average.
| ARKM | BIO | |
|---|---|---|
Market Cap | Rp450,94M | Rp1,13T |
Volume (24h) | Rp516,11M | Rp315,29M |
Circulating Supply | 225,1M / 1B ARKM (23%) | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 49 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
ARKM is currently trading at Rp1,971 with a bearish technical signal, showing selling pressure across moving averages while oscillators remain neutral. The token trades below the pivot point of Rp2,048 with immediate support at Rp1,951. With only 23% of the maximum 1 million token supply in circulation and an average hold time of 49 days, the asset shows limited distribution but stable holding patterns among current investors.
The overall outlook remains cautious due to strong bearish technical signals and limited fundamental developments. Key opportunities include potential price stabilization near support levels, while major risks involve low liquidity with Rp453.71M market cap and the absence of recent ecosystem updates that could drive adoption.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
What Pluang investors did over the last 30 days
Arkham is a blockchain analysis platform that uses artificial intelligence to deanonymize the blockchain and on-chain data. Arkham’s platform can be used for various purposes, such as tracking stolen funds, identifying fraudsters, verifying counterparties, auditing transactions, investigating hacks, and more. Arkham claims its platform can help combat the proliferation of crypto crimes and scams by incentivizing on-chain research.
Read more on ARKM →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →